[What is the status of drugs of biological origin (rules, safety, ethical prerequisites?]
Related Experiment Videos
1Immunotech SA, Marseille, France.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.
European journal of nuclear medicine and molecular imaging·2020
Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2015
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs.
Bone marrow transplantation·2011
Pharmacological Analysis of P2Y Purinergic Receptors That Modulate the Rat Vasopressor Sympathetic Tone.
Pharmaceuticals (Basel, Switzerland)·2026
A mechanistic PK/PD model of fentanyl overdose and intranasal naloxone rescue incorporating receptor-level competition.
Journal of pharmacokinetics and pharmacodynamics·2026